Innovivaalready appears to be reneging on its vague recent promise to deliver cost cuts Innovivafails to acknowledge that its abysmal corporate governance practices must be fixed
INNOVIVA WILL NOT CHANGE WITHOUT SHAREHOLDER REPRESENTATION AND OVERSIGHT
Sarissa corrects the record with regard to further misstatements by
Innovivacontinues to grossly overstate its role in GSK’s sales and marketing Innoviva’sindependent directors have been barely present during the nomination process, unlike CEO Innovivaneeds to learn from Enzon how to run a company for the benefit of shareholders and not management
Innoviva Contradicts Itself on GSK Role – Sarissa finds
Innoviva’s Independent Directors Have Failed Their Critical Duties in Considering Sarissa’s Nominees –
In addition, George Bickerstaff III and
We have had very positive conversations with many of
WE URGE ALL SHAREHOLERS TO VOTE NOW ON THE GOLD CARD FOR THE SARISSA NOMINEES.
If you have any questions regarding your GOLD proxy card or need assistance in voting, please contact our proxy solicitor:
STOCKHOLDERS CALL TOLL−FREE: (800) 549−6746
BANKS AND BROKERAGE FIRMS CALL: (212) 269−5550
Time is of the essence. We urge you to VOTE THE GOLD PROXY CARD to help us fix the problems at Innoviva. If you want to follow the recommendations of ISS, Glass Lewis and Egan-Jones and vote for Sarissa nominees YOU MUST VOTE ON THE GOLD CARD AND YOU CANNOT VOTE THE WHITE CARD. Returning a white card, even if you withhold on
CERTAIN INFORMATION CONCERNING THE PARTICIPANTS
Consent of the author and publication to use the quotations contained in the material filed herewith as proxy soliciting material was neither sought nor obtained.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sarissa-capital-states-innoviva-already-appears-to-renege-on-cost-cuts-innoviva-thinks-its-bad-corporate-governance-is-not-a-problem-300440397.html